03/26/2024
3:53 PM | Cognition Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/26/2024
3:16 PM | Cognition Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/26/2024
6:12 AM | Cognition Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/14/2024
3:34 PM | Cognition Therapeutics (Issuer)
Ricciardi Lisa (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/13/2024
3:04 PM | Cognition Therapeutics (Filer)
| Form 424B5 | |
03/13/2024
3:07 PM | Cognition Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/20/2024
3:44 PM | Cognition Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
02/09/2024
6:11 PM | Cognition Therapeutics (Issuer)
Ricciardi Lisa (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/09/2024
6:12 PM | Caggiano Anthony (Reporting)
Cognition Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/07/2024
6:01 PM | Cognition Therapeutics (Subject)
HIRSCHMAN ORIN (Filed by)
| Form SC 13G/A | |
01/19/2024
2:07 PM | Cognition Therapeutics (Subject)
PATHSTONE FAMILY OFFICE, LLC (Filed by)
| Form SC 13G | |
01/08/2024
11:15 PM | Cognition Therapeutics (Filer)
| Form EFFECT | |
01/04/2024
3:21 PM | Cognition Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/13/2023
4:17 PM | Bios Clinical Opportunity Fund, LP (Reporting)
Bios Equity COF, LP (Reporting)
Cognition Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
11/13/2023
4:25 PM | BIOS Memory SPV I, LP (Filed by)
Cognition Therapeutics (Subject)
| Form SC 13D/A | |
11/13/2023
8:47 AM | BIOS Advisors GP, LLC (Reporting)
BIOS Advisors GP, LLC (Reporting)
BIOS Capital Management, LP (Reporting)
Bios Equity Partners II, LP (Reporting)
Bios Equity Partners, LP (Reporting)
Bios Equity Partners, LP (Reporting)
BIOS Fund I QP, LP (Reporting)
BIOS Fund I QP, LP (Reporting)
BIOS Fund I, LP (Reporting)
BIOS Fund I, LP (Reporting)
BIOS Fund II QP, LP (Reporting)
BIOS Fund II QP, LP (Reporting)
BIOS Fund II, LP (Reporting)
BIOS Fund II, LP (Reporting)
BIOS Memory SPV I, LP (Reporting)
BIOS Memory SPV I, LP (Reporting)
Cognition Therapeutics (Issuer)
Cognition Therapeutics (Issuer)
Fletcher Aaron G.L. (Reporting)
Fletcher Aaron G.L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/13/2023
8:48 AM | BIOS Equity Partners III, LP (Reporting)
BIOS Fund II NT, LP (Reporting)
BIOS Fund II NT, LP (Reporting)
BIOS Fund III NT, LP (Reporting)
BIOS Fund III NT, LP (Reporting)
BIOS Fund III QP, LP (Reporting)
BIOS Fund III QP, LP (Reporting)
BIOS Fund III, LP (Reporting)
BIOS Fund III, LP (Reporting)
BIOS Memory SPV II, LP (Reporting)
BIOS Memory SPV II, LP (Reporting)
BP Directors, LP (Reporting)
BP Directors, LP (Reporting)
Cavu Advisors, LLC (Reporting)
Cavu Advisors, LLC (Reporting)
Cavu Management, LP (Reporting)
Cavu Management, LP (Reporting)
Cognition Therapeutics (Issuer)
Cognition Therapeutics (Issuer)
Kreis Leslie W. (Reporting)
Kreis Leslie W. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/02/2023
6:41 AM | Cognition Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/02/2023
6:45 AM | Cognition Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
09/12/2023
6:00 AM | Cognition Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/24/2023
6:00 AM | Cognition Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/08/2023
6:16 AM | Cognition Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/08/2023
6:05 AM | Cognition Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/28/2023
6:27 AM | Cognition Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/28/2023
6:32 AM | Cognition Therapeutics (Filer)
| Form 424B5 | |
06/13/2023
7:01 PM | BIOS Advisors GP, LLC (Reporting)
BIOS Capital Management, LP (Reporting)
Bios Equity Partners II, LP (Reporting)
Bios Equity Partners, LP (Reporting)
BIOS Fund I QP, LP (Reporting)
BIOS Fund I, LP (Reporting)
BIOS Fund II QP, LP (Reporting)
BIOS Fund II, LP (Reporting)
BIOS Memory SPV I, LP (Reporting)
Cognition Therapeutics (Issuer)
Fletcher Aaron G.L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2023
7:02 PM | BIOS Equity Partners III, LP (Reporting)
BIOS Fund II NT, LP (Reporting)
BIOS Fund III NT, LP (Reporting)
BIOS Fund III QP, LP (Reporting)
BIOS Fund III, LP (Reporting)
BIOS Memory SPV II, LP (Reporting)
Cavu Advisors, LLC (Reporting)
Cavu Management, LP (Reporting)
Cognition Therapeutics (Issuer)
Kreis Leslie W. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2023
4:37 PM | Cognition Therapeutics (Issuer)
Khattar Jack A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2023
4:38 PM | Cognition Therapeutics (Issuer)
RICHSTONE ELLEN B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2023
4:38 PM | Cognition Therapeutics (Issuer)
Wallace Peggy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2023
4:39 PM | Cognition Therapeutics (Issuer)
Monia Brett P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2023
6:41 AM | Cognition Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/04/2023
3:06 PM | Cognition Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/01/2023
6:30 AM | Cognition Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
